Literature DB >> 17607184

Experimental models of multiple sclerosis.

H Lassmann1.   

Abstract

Multiple sclerosis is considered an autoimmune disease, which leads to inflammatory demyelinating plaques in the white matter of the central nervous system (CNS). Recent studies on MS pathology, however, show that the disease is complex and heterogeneous. Essentially similar lesions, as those seen in MS, can be induced in experimental animals by auto-immunization with brain antigens. This model, experimental autoimmune encephalomyelitis, thus is commonly used to study pathogenesis of the disease and to test new therapeutic approaches. However, EAE reflects only part of the pathological spectrum of MS. In addition, many different EAE models are available, which cover specific aspects of the disease, but there is no single EAE model, which mimicks MS as a whole. For these reasons EAE, in its broad spectrum, is a useful model to study specific questions of MS pathology and pathogenesis, but its usefulness for testing new MS therapies is limited. In addition, proper selection of the best suited EAE model for a specific study is essential.

Entities:  

Mesh:

Year:  2007        PMID: 17607184     DOI: 10.1016/s0035-3787(07)90474-9

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  16 in total

1.  Targeted Stage-Specific Inflammatory microRNA Profiling in Urine During Disease Progression in Experimental Autoimmune Encephalomyelitis: Markers of Disease Progression and Drug Response.

Authors:  Jaspreet Singh; Mandar Deshpande; Hamid Suhail; Ramandeep Rattan; Shailendra Giri
Journal:  J Neuroimmune Pharmacol       Date:  2015-08-16       Impact factor: 4.147

2.  CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis.

Authors:  LiPing Liu; Abdelmadjid Belkadi; Lindsey Darnall; Taofang Hu; Caitlin Drescher; Anne C Cotleur; Dolly Padovani-Claudio; Tao He; Karen Choi; Thomas E Lane; Robert H Miller; Richard M Ransohoff
Journal:  Nat Neurosci       Date:  2010-02-14       Impact factor: 24.884

Review 3.  CD8+ Tregs in lupus, autoimmunity, and beyond.

Authors:  Ravi K Dinesh; Brian J Skaggs; Antonio La Cava; Bevra H Hahn; Ram Pyare Singh
Journal:  Autoimmun Rev       Date:  2010-04-10       Impact factor: 9.754

4.  Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis.

Authors:  J Singh; M Cerghet; L M Poisson; I Datta; K Labuzek; H Suhail; R Rattan; Shailendra Giri
Journal:  J Neuroimmune Pharmacol       Date:  2018-10-12       Impact factor: 4.147

Review 5.  Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).

Authors:  Cris S Constantinescu; Nasr Farooqi; Kate O'Brien; Bruno Gran
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

6.  Growth factor regulation of remyelination: behind the growing interest in endogenous cell repair of the CNS.

Authors:  Regina C Armstrong
Journal:  Future Neurol       Date:  2007-11

7.  Accelerated course of experimental autoimmune encephalomyelitis in PD-1-deficient central nervous system myelin mutants.

Authors:  Antje Kroner; Nicholas Schwab; Chi Wang Ip; Sonja Ortler; Kerstin Göbel; Klaus-Armin Nave; Mathias Mäurer; Rudolf Martini; Heinz Wiendl
Journal:  Am J Pathol       Date:  2009-05-14       Impact factor: 4.307

8.  Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis.

Authors:  Rina Aharoni; Avia Herschkovitz; Raya Eilam; Michal Blumberg-Hazan; Michael Sela; Wolfgang Bruck; Ruth Arnon
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-04       Impact factor: 11.205

Review 9.  Complement in multiple sclerosis: its role in disease and potential as a biomarker.

Authors:  G Ingram; S Hakobyan; N P Robertson; B P Morgan
Journal:  Clin Exp Immunol       Date:  2008-11-24       Impact factor: 4.330

10.  Autoantibodies to Non-myelin Antigens as Contributors to the Pathogenesis of Multiple Sclerosis.

Authors:  Michael C Levin; Sangmin Lee; Lidia A Gardner; Yoojin Shin; Joshua N Douglas; Chelsea Cooper
Journal:  J Clin Cell Immunol       Date:  2013-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.